Back to VA VANGUARD CAPITAL MANAGEMENT LLC
LYEL2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in LYELL IMMUNOPHARMA INC
VANGUARD CAPITAL MANAGEMENT LLC holds 786,774 shares of LYEL (LYELL IMMUNOPHARMA INC), worth $11.1M as of 2026-Q2. The position was increased (+9.6% shares). LYEL represents 0.0% of VANGUARD CAPITAL MANAGEMENT LLC's portfolio.
Current Value
$11.1M
Current Shares
786,774
Total Value Change
-$3.4M
Total Shares Change
+68,619
Quarter-by-Quarter History
Other major holders of LYEL: VANGUARD GROUP INC, BlackRock, Inc., CITADEL ADVISORS LLC, MILLENNIUM MANAGEMENT LLC